The invention provides novel processes and appropriate experimental techniques which would maximize antigen yield, and also stabilize Vero-cell derived purified inactivated Japanese encephalitis virus bulk. Alternative methods of cell culture and virus culture are disclosed for commercial manufacture of vaccine formulations. The stabilized inactivated virus bulk can be stored for a long time at 2°C -8°C until vaccine formulation